Am J Transplant, Volume 19, Suppl 3 Archives - Page 155 of 214 - ATC Abstracts

2019 American Transplant Congress
Desensitization Using Only IVIG: Is That an Option for Highly-Sensitized Patients Waiting for Kidneys from Cadaveric Donors?
J. O. Paixão, L. R. Ulisses, P. S. Souza, G. Bezerra, F. Agena, H. P. Rodrgues, N. Panajotopoulos, F. J. Paula, E. David-Neto, M. R. Castro
Nefrologia, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil
*Purpose: The reduction of anti-HLA has been proven to be efficient and safe in transplants of highly-sensitized with living donors (LD). The results of adopting…
2019 American Transplant Congress
Alemtuzumab versus Antithymocyte Globulin Induction Immunosuppression in Highly Sensitized Kidney Transplant Recipients
A. Brueckner¹, E. Yanqui¹, C. Truong¹, R. Baliga², L. Bowman¹
¹Tampa General Hospital, Tampa, FL, ²Florida Kidney Physicians, Tampa, FL
*Purpose: Lymphocyte depleting agents such as rabbit anti-thymocyte globulin (rATG) and alemtuzumab are used for induction in highly sensitized (PRA ≥30%) kidney transplant recipients (KTRs).…
2019 American Transplant Congress
Low-Dose Valacyclovir Prophylaxis for Cytomegalovirus Infection in Renal Transplant Recipients with Intermediate Risk
A. Velioglu¹, H. Arikan¹, E. Asicioglu¹, S. Alagoz², N. Seyahi², S. Tuglular¹, C. Ozener¹
¹Nephrology, Marmara University School of Medicine, İstanbul, Turkey, ²Nephrology, Istanbul University, Cerrahpasa Medical School, İstanbul, Turkey
*Purpose: According to recent guidelines ganciclovir or valganciclovir chemoprophylaxis is recommended for all kidney transplantation (KT) recipients (except for D-/R- serology) for preventing cytomegalovirus (CMV)…
2019 American Transplant Congress
Kidney Biopsies In Hiv-negative To Hiv-positive Kidney Transplants – An Institutional Experience
V. Walavalkar¹, A. Zarinsefat², A. Urisman¹, D. Dobi¹, J. Vasquez³, P. Stock², Z. Laszik¹
¹Pathology, UCSF Medical Center, San Francisco, CA, ²Transplant Surgery, UCSF Medical Center, San Francisco, CA, ³Medicine, UCSF Medical Center, San Francisco, CA
*Purpose: Increased life expectancy in HIV+ patients has resulted in an increase in CKD leading to ESRD; and therefore renal transplantation in these individuals is…
2019 American Transplant Congress
Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation
R. D. Reed¹, V. Kumar¹, B. Berry¹, D. Hendricks¹, A. Carter¹, B. A. Shelton¹, M. N. Mustian¹, P. A. MacLennan¹, H. Qu¹, L. Hannon², C. Yates², M. J. Hanaway¹, J. E. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²Tuskegee University, Tuskegee, AL
*Purpose: No living donation program has addressed transplant candidate factors by separating the advocacy role from the candidates while simultaneously addressing potential living donor concerns…
2019 American Transplant Congress
Arterial Blood Pressure Circadian Rhythm in Renal Transplant Recipients
A. M. Arriaga, Y. J. Lopez, J. A. Cedillo, L. A. Marino, J. M. Mejia, I. Parra, A. Cohen, L. E. Morales
Nephrology, National Institute of Medical Sciences and Nutrition Salvador Zubirán,, Mexico City, Mexico
*Purpose: Approximately 80% kidney transplant (KT) recipients have high blood pressure, compromising graft survival and increasing cardiovascular risk. In the pre-transplant stage, alterations in blood…
2019 American Transplant Congress
Surgical Outcome and Analysis of Risk of Complications in Kidney Donors Receiving Laparoscopic Live Donor Nephrectomy
C. Yang, C. Yeh, C. Lee, C. Chen, I. Lai, P. Lee, M. Tsai
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
*Purpose: Laparoscopic live donor nephrectomy has adopted for more than 20 years. But the operative procedure is still technically demanding, and allows almost no margin…
2019 American Transplant Congress
Guideline Adherence for Secondary Prevention of Stroke and Atherosclerotic Cardiovascular Disease among Liver Transplant Recipients
P. T. Campbell¹, M. Kosirog¹, S. Montag², S. Connolly¹, A. Daud³, A. Das¹, S. Pine¹, D. Finn³, J. Levitsky¹, J. L. Holl⁴, D. M. Lloyd-Jones⁵, L. B. VanWagner⁶
¹Division of GI and Hepatology, Department of Medicine, Northwestern University, Chicago, IL, ²Department of Preventive Medicine, Northwestern University, Chicago, IL, ³Center for Healthcare Studies, Northwestern University, Chicago, IL, ⁴Department of Pediatrics and Center for Healthcare Studies, Northwestern University, Chicago, IL, ⁵Departments of Preventive Medicine and Medicine-Cardiology, Northwestern University, Chicago, IL, ⁶Division of GI and Hepatology, Department of Medicine and Department of Preventive Medicine, Northwestern University, Chicago, IL
*Purpose: Data about provider adherence to clinical practice guidelines for secondary prevention of stroke and atherosclerotic cardiovascular disease (ASCVD) among liver transplant recipients (LTRs), which…
2019 American Transplant Congress
Incidence and Risks for Non-alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Reveiw and Meta-Analysis
N. Saeed¹, P. Sharma², L. Glass², C. Shannon², C. Sonnenday², M. Konerman²
¹Beaumont Hospital, Ann Arbor, MI, ²University of Michigan, Ann Arbor, MI
*Purpose: Recurrent and denovo non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH) are important post-liver transplant (LT) outcomes given risk to graft viability. The true…
2019 American Transplant Congress
Clinical Outcomes of Patients with Portal Vein Tumor Thrombi after Living Donor Liver Transplantation
D. Kim
Surgery, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Patient selection criteria for living donor liver transplantation(LDLT) with hepatocellular carcinoma are generally wider than those for deceased donor liver transplantation. It is widely…